Search Results

There are 6864 results for: content related to: Intravenous administration of desmopressin acetate to reverse acetylsalicylic acid-induced coagulopathy in three dogs

  1. Desmopressin use for minimising perioperative allogeneic blood transfusion

    Intervention Review

    The Cochrane Library

    Michael Desborough, Lise J Estcourt, Carolyn Doree, Marialena Trivella and Simon J Stanworth

    Published Online : 26 JAN 2004, DOI: 10.1002/14651858.CD001884.pub2

  2. You have free access to this content
    DDAVP IS NOT A PANACEA FOR CHILDREN WITH BLEEDING DISORDERS

    British Journal of Haematology

    Volume 108, Issue 2, February 2000, Pages: 217–227, Sutor

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2141.2000.01814.x

  3. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype

    Haemophilia

    Volume 18, Issue 1, January 2012, Pages: 50–55, M. E. SEARY, D. FELDMAN and M. D. CARCAO

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1365-2516.2011.02572.x

  4. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: Molecular dynamics simulation of the agonist-bound state in the membrane–aqueous system

    Biopolymers

    Volume 81, Issue 5, 5 April 2006, Pages: 321–338, Magdalena J. Ślusarz, Rafał Ślusarz and Jerzy Ciarkowski

    Version of Record online : 6 DEC 2005, DOI: 10.1002/bip.20420

  5. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders

    Haemophilia

    Volume 20, Issue 2, March 2014, Pages: 158–167, C. Leissinger, M. Carcao, J. C. Gill, J. Journeycake, T. Singleton and L. Valentino

    Version of Record online : 12 AUG 2013, DOI: 10.1111/hae.12254

  6. You have free access to this content
    Vasopressin-stimulated CFTR Cl currents are increased in the renal collecting duct cells of a mouse model of Liddle's syndrome

    The Journal of Physiology

    Volume 562, Issue 1, January 2005, Pages: 271–284, Chiz-Tzung Chang, Marcelle Bens, Edith Hummler, Sheerazed Boulkroun, Laurent Schild, Jacques Teulon, Bernard C. Rossier and Alain Vandewalle

    Version of Record online : 22 DEC 2004, DOI: 10.1113/jphysiol.2004.077933

  7. You have free access to this content
    Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 4, April 2003, Pages: 682–689, J. E. Kaufmann and U. M. Vischer

    Version of Record online : 21 MAR 2003, DOI: 10.1046/j.1538-7836.2003.00190.x

  8. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders

    Haemophilia

    Volume 14, Issue 3, May 2008, Pages: 524–530, F. L. HANEBUTT, N. ROLF, A. LOESEL, E. KUHLISCH, G. SIEGERT and R. KNOEFLER

    Version of Record online : 18 FEB 2008, DOI: 10.1111/j.1365-2516.2008.01672.x

  9. ACTH and cortisol release following intravenous desmopressin: a dose–response study

    Clinical Endocrinology

    Volume 51, Issue 5, November 1999, Pages: 653–658, Lucinda V. Scott, Sami Medbak and Timothy G. Dinan

    Version of Record online : 12 MAY 2003, DOI: 10.1046/j.1365-2265.1999.00850.x

  10. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders

    Haemophilia

    Volume 22, Issue 5, September 2016, Pages: 700–705, J. A. Mason, J. D. Robertson, J. McCosker, B. A. Williams and S. A. Brown

    Version of Record online : 6 JUL 2016, DOI: 10.1111/hae.12949

  11. You have free access to this content
    A Systematic Review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy

    Haemophilia

    Volume 18, Issue 1, January 2012, Pages: 25–33, D. E. TRIGG, I. STERGIOTOU, P. PEITSIDIS and R. A. KADIR

    Version of Record online : 30 MAY 2011, DOI: 10.1111/j.1365-2516.2011.02573.x

  12. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease

    Haemophilia

    Volume 14, Issue 3, May 2008, Pages: 539–548, A. SHARTHKUMAR, A. GREIST, J. DI PAOLA, J. WINAY, C. ROBERSON, M. HEIMAN, S. HERBERT, R. PARAMESWARAN and A. SHAPIRO

    Version of Record online : 25 FEB 2008, DOI: 10.1111/j.1365-2516.2008.01666.x

  13. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977–2007)

    Haemophilia

    Volume 14, Issue s1, January 2008, Pages: 5–14, A. B. FEDERICI

    Version of Record online : 21 DEC 2007, DOI: 10.1111/j.1365-2516.2007.01610.x

  14. You have free access to this content
    Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization

    Haemophilia

    Volume 10, Issue 3, May 2004, Pages: 218–231, K. J. Pasi, P. W. Collins, D. M. Keeling, S. A. Brown, A. M. Cumming, G. C. Dolan, C. R. M. Hay, F. G. H. Hill, M. Laffan and I. R. Peake

    Version of Record online : 11 MAR 2004, DOI: 10.1111/j.1365-2516.2004.00886.x

  15. Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

    Haemophilia

    Volume 22, Issue 1, January 2016, Pages: 110–120, J. Windyga, G. Dolan, C. Altisent, O. Katsarou, M.-F. López Fernández, B. Zülfikar and on behalf of the EHTSB

    Version of Record online : 24 JUL 2015, DOI: 10.1111/hae.12763

  16. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis

    Clinical Endocrinology

    Volume 49, Issue 6, December 1998, Pages: 793–801, J. M. Hunsballe, T. K. Hansen, S. Rittig, E. B. Pedersen and J. C. Djurhuus

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2265.1998.00587.x

  17. High-dose DDAVP intranasal spray (Stimate®) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

    Haemophilia

    Volume 7, Issue 3, May 2001, Pages: 258–266, C. Leissinger, D. Becton, C. Cornell and J. Cox Gill

    Version of Record online : 21 DEC 2001, DOI: 10.1046/j.1365-2516.2001.00500.x

  18. Intracellular Calcium Increase and Somatodendritic Vasopressin Release by Vasopressin Receptor Agonists in the Rat Supraoptic Nucleus: Involvement of Multiple Intracellular Transduction Signals

    Journal of Neuroendocrinology

    Volume 16, Issue 3, March 2004, Pages: 221–236, N. Sabatier, I. Shibuya and G. Dayanithi

    Version of Record online : 26 MAR 2004, DOI: 10.1111/j.0953-8194.2004.01155.x

  19. Pre-treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex-vivo model of swine-to-human pulmonary xenotransplantation

    Xenotransplantation

    Volume 15, Issue 1, February 2008, Pages: 27–35, Young Tae Kim, Hyun Joo Lee, Sang Woo Lee, Ji Yeon Kim, Hyun Cho Wi, Sun Jung Park, Sung Jin Bae and Hee Jung Kang

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1399-3089.2008.00445.x

  20. Potent antidiuretic agonists, deamino-vasopressin and desmopressin, and their inverso analogs: NMR structure and interactions with micellar and liposomic models of cell membrane

    Peptide Science

    Volume 106, Issue 3, May 2016, Pages: 245–259, Emilia A. Lubecka, Emilia Sikorska, Dariusz Sobolewski, Adam Prahl, Jiřina Slaninová and Jerzy Ciarkowski

    Version of Record online : 23 MAY 2016, DOI: 10.1002/bip.22825